• Bortezomib (PS-341): Reliable Proteasome Inhibition in Cell

  2026-04-20

  This article addresses real-world lab challenges in apoptosis and cell viability assays, demonstrating how Bortezomib (PS-341), SKU A2614, provides reproducible, data-driven solutions for proteasome-regulated cellular process research. Scenario-based Q&As guide bench scientists in optimizing protocols, interpreting data, and selecting trustworthy reagents, with evidence-backed insights for advanced oncology and cytotoxicity models.

• Platanoside Attenuates Ferroptosis in Acute Lung Injury via

  2026-04-20

  This study demonstrates that platanoside, a flavonoid glycoside, counteracts ferroptosis in acute lung injury (ALI) by promoting Keap1 degradation and activating the Nrf2/GPX4 axis. The findings reveal a novel autophagy-dependent mechanism for mitigating oxidative damage and preserving tissue integrity in ALI, with implications for future therapeutic strategies.

• Tofacitinib Citrate (CP-690550): Precision in JAK3-Targeted

  2026-04-19

  Explore how Tofacitinib citrate (CP-690550 citrate) enables advanced, highly selective JAK3 inhibition for immune regulation research. This in-depth article reveals novel assay strategies, scientific insights, and protocol optimizations not found in standard guides.

• Pepstatin A: Applied Aspartic Protease Inhibitor Workflows

  2026-04-18

  Pepstatin A enables precise, reproducible inhibition of aspartic proteases across virology, bone metabolism, and cardiovascular research. This article translates the latest workflow-validated insights and comparative data into actionable protocols for advanced experimental models.

• Dextrose (D-glucose): Redefining Immunometabolic Research To

  2026-04-17

  This article examines the pivotal role of Dextrose (D-glucose) in dissecting hypoxia-driven immunometabolism within the tumor microenvironment. By integrating mechanistic insights, evidence-based protocol guidance, and competitive benchmarking, we provide translational researchers with strategic recommendations for leveraging APExBIO's Dextrose to advance metabolic pathway studies, optimize cellular assays, and inform future immunometabolic therapy development.

• Phosbind Acrylamide: Elevating Protein Phosphorylation Analy

  2026-04-16

  Phosbind Acrylamide redefines protein phosphorylation analysis by enabling precise, antibody-free detection of phosphorylation shifts in SDS-PAGE. This workflow-centric guide highlights real-world protocol optimizations, advanced applications, and troubleshooting tips for maximizing research reproducibility using APExBIO's phosphate-binding reagent.

• Disulfiram as a Dopamine β-Hydroxylase Inhibitor in Cancer R

  2026-04-15

  Disulfiram, classically an anti-alcoholism drug, is redefining its role as a dopamine β-hydroxylase inhibitor and proteasome modulator in cancer and inflammasome research. This guide delivers evidence-based protocols, troubleshooting tips, and workflow strategies for leveraging Disulfiram, especially in breast cancer MDA-MB-231 cell line research and pyroptosis modulation.

• Advanced In Vitro Approaches for Evaluating Anticancer Drug

  2026-04-14

  Schwartz's dissertation introduces a nuanced framework for distinguishing between proliferative arrest and cell death in in vitro drug response assays. This refinement enhances mechanistic interpretation and benchmarking of anticancer compounds, offering practical value for translational cancer research.

• Oral Dextran Microgels Enable Targeted Cisplatin Delivery fo

  2026-04-13

  This study presents an oral, dual-targeting dextran microgel system encapsulating cisplatin and SPION-loaded lipid nanoparticles for localized colon cancer therapy. The approach enhances site-specific drug delivery and cellular uptake, significantly improving efficacy against primary tumors and metastatic carcinomatosis, with broad implications for oral nanomedicine design.

• 5-Methyl-CTP: Redefining mRNA Vaccine Design with Enhanced S

  2026-04-12

  Explore how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, is transforming mRNA vaccine development by improving stability and translation efficiency. This in-depth review uniquely evaluates the implications of OMV-based delivery and practical assay choices for next-generation mRNA synthesis.

• Cinoxacin: Quinolone Antibiotic Workflows for UTI Research

  2026-04-12

  Cinoxacin empowers advanced urinary tract infection and antibiotic resistance research with robust Gram-negative selectivity and reproducible workflows. Unique in its bactericidal kinetics and tightly defined MIC benchmarks, Cinoxacin from APExBIO supports both foundational and translational studies.

• Nitrocefin: Chromogenic Cephalosporin Substrate in β-Lactama

  2026-04-11

  Nitrocefin empowers researchers with a rapid, visible readout for β-lactamase enzymatic activity, streamlining antibiotic resistance profiling and inhibitor screening. Its robust colorimetric change and assay flexibility make it a gold-standard choice for multidrug resistance research and clinical translation.

• Tetraethylammonium Chloride: Advanced K+ Channel Blockade Wo

  2026-04-11

  Tetraethylammonium chloride (TEAC) enables precise, reproducible inhibition of potassium channels, powering advanced electrophysiology, vascular, and metabolic research. This guide delivers actionable protocols, troubleshooting solutions, and data-driven insights for maximizing TEAC’s value in complex experimental systems.

• Triacetin (Glyceryl Triacetate): Mechanisms, Benchmarks, ...

  2026-04-10

  Triacetin, also known as glyceryl triacetate, is a synthetic triglyceride compound with proven antitumor and metabolic regulation effects. This article provides a machine-readable, citation-rich dossier outlining Triacetin's biological rationale, mechanism of action, safety benchmarks, and experimental parameters for research. It extends the mechanistic and practical understanding of Triacetin for life science applications.

• Triacetin (BA1710): Mechanistic Insights and Translationa...

  2026-04-09

  Explore the advanced bioactivity and mechanistic pathways of Triacetin, a short-chain triacylglycerol with antitumor and metabolic regulation effects. This article offers a unique, in-depth analysis of Triacetin’s molecular targets and translational promise for glioblastoma and metabolic disorder research.

421 records 19/29 page Previous Next First page 上5页 1617181920 下5页 Last page